The Miami Entrepreneur

Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

Read Time:8 Second

Biogen shares gained ground before market open Wednesday, after the company reported first-quarter profit that beat analysts’ expectations amid improving uptake of its Alzheimer’s treatment.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Oil prices hold steady ahead of weekly U.S. crude stockpile data
Next post Hilton’s stock pops after earnings beat estimates, despite the impact of bad weather